Jennifer Good | President and Chief Executive Officer |
William Forbes | Chief Development Officer |
Lisa Delfini | Chief Financial Officer |
Annabel Samimy | Stifel |
Nathan Weinstein | Aegis Capital |
Good afternoon, and welcome to the Trevi Therapeutics Q4 and Year End 2021 Earnings Conference Call. At this time, all participants will be in listen-only mode. [Operator Instructions] After today's presentation there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. Various remarks the management makes during this call about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995.